Danaher Corporation $DHR is Defender Capital LLC.’s 4th Largest Position

Defender Capital LLC. cut its position in shares of Danaher Corporation (NYSE:DHR) by 5.6% during the 2nd quarter, Holdings Channel.com reports. The firm owned 148,716 shares of the conglomerate’s stock after selling 8,813 shares during the period. Danaher accounts for approximately 9.2% of Defender Capital LLC.’s holdings, making the stock its 4th largest holding. Defender Capital LLC.’s holdings in Danaher were worth $28,327,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. State Street Corp grew its position in Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after acquiring an additional 472,608 shares during the last quarter. Capital International Investors lifted its holdings in shares of Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after acquiring an additional 1,487,768 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Danaher by 9.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after acquiring an additional 1,334,221 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Danaher by 11.2% in the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after purchasing an additional 1,517,904 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Danaher in the 4th quarter valued at $2,177,106,000. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DHR. Stifel Nicolaus decreased their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Robert W. Baird reduced their price objective on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Finally, Barclays dropped their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Stock Performance

Shares of NYSE:DHR opened at $208.92 on Tuesday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average price of $191.24 and a 200-day moving average price of $193.84. The company has a market cap of $146.87 billion, a price-to-earnings ratio of 37.11, a price-to-earnings-growth ratio of 2.55 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the firm earned $0.77 earnings per share. Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.